The DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Abstract
Breast cancer development largely depends upon the essential contributions from the tumor microenvironment, where several inflammatory cell populations (e.g. macrophages) orchestrate breast cancer development. The majority of tumor-associated macrophages (TAMs) exhibit alternatively activated M2 properties, produce abundant anti-inflammatory factors and facilitate tumor development. Clinical evidences compellingly indicate the association between high TAMs influx and poor prognosis in patients with breast cancers. The pan-macrophage marker CD68 is now generally utilized to identify TAMs in diagnostic biopsy samples, and some other TAM-related biomarkers are also utilized in prognosis prediction, including CD163, vascular endothelial growth factor (VEGF), hypoxia-inducible factors (HIFs), proliferating cellular nuclear antigen (PCNA), ferritin light chain (FTL) and C-C motif chemokine ligand 18 (CCL18). In this review, we highlight the recent progress made in understanding the relationship between TAMs and clinicopathological parameters in human breast cancer and address the potential value of TAMs as diagnostic and prognostic biomarkers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the appearance of tumor-supporting, iron-donating immune cells, in particular macrophages, is associated with tumor size and aggressiveness as well as poor patient prognosis [56,57].”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [56]
Citations
Cites
1 retracted
Yamamoto, N., Suyama, H., Yamamoto, N., & Ushijima, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.23107 · Cited by 62
RetractedExploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L. D., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,456
Breast cancer statistics, 2013
Desantis, C. E., Ma, J., Bryan, L. N., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,142
Ma, J., & Jemal, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,918
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Breast cancer statistics, 2011
Desantis, C. E., Siegel, R. L., Bandi, P., & Jemal, A. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20134 · Cited by 1,338
Movahedi, K., Laoui, D., Gysemans, C. A., Baeten, M., Stangé, G. M., den Bossche, J. V., Mack, M., PIPELEERS, D. G., Veld, P. I. '., BAETSELIER, P. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,268
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S. J., Iqbal, J., Weisenburger, D. D., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905680 · Cited by 1,262
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S. K., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,089
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044
Heterogeneity in breast cancer
Polyák, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60534 · Cited by 1,038
Medrek, C., Pontén, F., Jirström, K., & Leandersson, K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-306 · Cited by 676
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Chen, J., Yao, Y., Gong, C., Yu, F., Su, S., Chen, J., Liu, B., Deng, H., Wang, F., Lin, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.006 · Cited by 645
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Luo, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27648 · Cited by 551
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011) · Genes & Development · doi:10.1101/gad.180331.111 · Cited by 541
Leukocyte composition of human breast cancer
Ruffell, B., Au, A., Rugo, H. S., Esserman, L. J., Hwang, E. S., & Coussens, L. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104303108 · Cited by 489
Jinushi, M., Chiba, S., Yoshiyama, H., Masutomi, K., Kinoshita, I., Dosaka-Akita, H., Yagita, H., Takaoka, A., & Tahara, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106645108 · Cited by 479
Tumor-Associated Macrophages Press the Angiogenic Switch in Breast Cancer
Lin, E. Y., & Pollard, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0912 · Cited by 463
Identification and manipulation of tumor associated macrophages in human cancers
Heusinkveld, M., & van der Burg, S. H. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-216 · Cited by 451
Leek, R., Landers, R. J., Harris, A. L., & Lewis, C. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690158 · Cited by 450
Differential regulation of iron homeostasis during human macrophage polarized activation
Recalcati, S., Locati, M., Marini, A., Santambrogio, P., Zaninotto, F., De Pizzol, M., Zammataro, L., Girelli, D., & Cairo, G. (2010) · European Journal of Immunology · doi:10.1002/eji.200939889 · Cited by 438
Biswas, S. K., Sica, A., & Lewis, C. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2011 · Cited by 432
Macrophages define the invasive microenvironment in breast cancer
Pollard, J. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107762 · Cited by 414
Tsutsui, S., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., & Era, S. (2005) · Oncology Reports · doi:10.3892/or.14.2.425 · Cited by 368
Sallari, R. C., Zhang, X., Wright, J. B., Bailey, S. D., Cole, M. D., Eeckhoute, J., Moore, J. H., & Lupien, M. (2012) · Nature Genetics · doi:10.1038/ng.2416 · Cited by 354
Tumor-Associated Macrophages in Breast Cancer
Leek, R., & Harris, A. L. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020304003704 · Cited by 353
Robinson, B. D., Sica, G., Liu, Y.-F., Rohan, T. E., Gertler, F. B., Condeelis, J. S., & Jones, J. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2179 · Cited by 345
MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles
Daldrup-Link, H. E., Golovko, D. M., Ruffell, B., DeNardo, D. G., Castaneda, R., Ansari, C., Rao, J., Tikhomirov, G. A., Wendland, M. F., Corot, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3420 · Cited by 307
Polarization dictates iron handling by inflammatory and alternatively activated macrophages
Corna, G., Campana, L., Pignatti, E., Castiglioni, A., Tagliafico, E., Bosurgi, L., Campanella, A., Brunelli, S., Manfredi, A. A., Apostoli, P., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023879 · Cited by 304 · cited 1×
“The molecular signature of the M1 macrophages show changes in gene expression (FTL repression and FTH induction) that favors iron sequestration in the reticuloendothelial system, whereas the M2 macrophages have an expression profile (FTL up-regulation and FTH down-regulation) that enhances iron release [70,71].”
BackgroundTumor-associated macrophages in breast cancer: distinct subsets, distinct functions
Laoui, D., Movahedi, K., Overmeire, E. V., den Bossche, J. V., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., BAETSELIER, P. D., & Ginderachter, J. A. V. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113371dl · Cited by 302
Yang, J., Liao, D., Chen, C., Liu, Y., Chuang, T.-H., Xiang, R., Markowitz, D., Reisfeld, R. A., & Luo, Y. (2013) · Stem Cells · doi:10.1002/stem.1281 · Cited by 301
Foekens, J. A., Peters, H. A., Grebenchtchikov, N. I., Look, M. P., Gelder, M. E. M., Geurts-Moespot, A. J., van der Kwast, T., Sweep, F. C. G. J., & Klijn, J. G. M. (2001) · PubMed · Cited by 294
Movahedi, K., Schoonooghe, S., Laoui, D., Houbracken, I., Waelput, W., Breckpot, K., Bouwens, L., Lahoutte, T., BAETSELIER, P. D., Raes, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2994 · Cited by 292
Anti‐tumour strategies aiming to target tumour‐associated macrophages
Tang, X., Mo, C., Wang, Y., Wei, D., & Xiao, H. (2012) · Immunology · doi:10.1111/imm.12023 · Cited by 288
Self-citationTumour-infiltrating macrophages and clinical outcome in breast cancer
Mahmoud, S., Lee, A. H. S., Paish, E. C., Macmillan, R. D., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200355 · Cited by 277
Campbell, M. J., Tonlaar, N., Garwood, E. R., Huo, D., Moore, D. H., Khramtsov, A., der Au, A., Baehner, F. L., Chen, Y., Malaka, D. O., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1154-y · Cited by 267
Expression of CD68 in Non‐Myeloid Cell Types
Gottfried, E., Kunz‐Schughart, L. A., Weber, A., Rehli, M., Peuker, A., Müller, A., Kastenberger, M., Brockhoff, G., Andreesen, R., & Kreutz, M. P. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02091.x · Cited by 261
Ojalvo, L. S., Whittaker, C. A., Condeelis, J. S., & Pollard, J. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902360 · Cited by 248
Shabo, I., Stål, O., Olsson, H., Doré, S., & Svanvik, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23527 · Cited by 225
High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors.
Ojalvo, L., King, W., Cox, D., & Pollard, J. (2009) · American Journal of Pathology · doi:10.2353/ajpath.2009.080676 · Cited by 223
Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer
Yang, L. P. H., Peng, X.-H., Wang, Y. A., Wang, X., Cao, Z., Ni, C., Karna, P., Zhang, X., Wood, W. C., Gao, X., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3289 · Cited by 216
Leek, R., Landers, R. J., Fox, S. B., Ng, F. C., Harris, A. L., & Lewis, C. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.373 · Cited by 207
Macrophage migration and gene expression in response to tumor hypoxia
Murdoch, C., & Lewis, C. E. (2005) · International Journal of Cancer · doi:10.1002/ijc.21422 · Cited by 203
Egeblad, M., Ewald, A. J., Askautrud, H. A., Truitt, M., Welm, B. E., Bainbridge, E. D., Peeters, G., Krummel, M. F., & Werb, Z. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000596 · Cited by 199
Leek, R., Talks, K., Pezzella, F., Turley, H., Campo, L., Brown, N. S., Bicknell, R., Taylor, M., Gatter, K. C., & Harris, A. L. (2002) · PubMed · Cited by 199
Brown, N. S., Jones, A., Fujiyama, C., Harris, A. L., & Bicknell, R. (2000) · PubMed · Cited by 187
Meng, Y., Beckett, M. A., Liang, H. L., Mauceri, H. J., van Rooijen, N., Cohen, K. S., & Weichselbaum, R. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2995 · Cited by 186
Molecular interactions in the Vogelstein model of colorectal carcinoma
Arends, J. W. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200003)190:4 · Cited by 184
Macrophages in human breast disease: a quantitative immunohistochemical study
Kelly, P., Davison, R., Bliss, E., & McGee, J. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.36 · Cited by 168
Eubank, T. D., Roberts, R. D., Khan, M., Curry, J. M., Nuovo, G. J., Kuppusamy, P., & Marsh, C. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1405 · Cited by 166
Valković, T., Dobrila, F., Melato, M., Sasso, F., Rizzardi, C., & Jonjić, N. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100458 · Cited by 152
Mukhtar, R. A., Nseyo, O., Campbell, M. J., & Esserman, L. J. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.97 · Cited by 142
89 Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging
Keliher, E. J., Yoo, J., Nahrendorf, M., Lewis, J. S., Marinelli, B. S., Newton, A., Pittet, M. J., & Weissleder, R. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200405d · Cited by 136
Expression of Vascular Notch Ligand Delta-Like 4 and Inflammatory Markers in Breast Cancer
Jubb, A. M., Soilleux, E. J., Turley, H., Steers, G., Parker, A., Low, I., Blades, J. S., Li, J., Allen, P. W., Leek, R., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090908 · Cited by 123
Bolat, F. A., Kayaselçuk, F., Nursal, T. Z., Yağmurdur, M. C., Bal, N., & Demirhan, B. (2006) · PubMed · Cited by 122
Verdoes, M., Edgington‐Mitchell, L. E., Scheeren, F. A., Leyva, M. J., Blum, G., Weiskopf, K., Bachmann, M. H., Ellman, J. A., & Bogyo, M. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.03.012 · Cited by 116
Leimgruber, A., Berger, C., Cortez‐Retamozo, V., Etzrodt, M., Newton, A., Waterman, P. R., de Figueiredo, J. L., Köhler, R. H., Elpek, N. M., Mempel, T. R., et al. (2009) · Neoplasia · doi:10.1593/neo.09356 · Cited by 112
Wood, G. W., & Gollahon, K. A. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/59.4.1081 · Cited by 97
Jézéquel, P., Campion, L., Spyratos, F., Loussouarn, D., Campone, M., Guérin‐Charbonnel, C., Joalland, M., André, J., Descotes, F., Grenot, C., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26397 · Cited by 85
Murri, A. M. A., Hilmy, M., Bell, J., Wilson, C., McNicol, A. M., Lannigan, A., Doughty, J., & McMillan, D. C. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604667 · Cited by 81
Gasparini, G. M., Fox, S. B., Verderio, P., Bonoldi, E., Bevilacqua, P., Boracchi, P., Dante, S., Marubini, E., & Harris, A. L. (1996) · PubMed · Cited by 69
Galmbacher, K., Heisig, M., Hotz, C., Wischhusen, J., Galmiche, A., Bergmann, B., Gentschev, I., Goebel, W., Rapp, U. R., & Fensterle, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009572 · Cited by 66
Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer.
Toi, M., Ueno, T., Matsumoto, H., Saji, H., Funata, N., Koike, M., & Tominaga, T. (1999) · PubMed · Cited by 63
Zohny, S. F., & Fayed, S. T. (2009) · Medical Oncology · doi:10.1007/s12032-009-9366-x · Cited by 54
Mukhtar, R. A., Moore, A. P., Nseyo, O., Baehner, F. L., Au, A., Moore, D. H., Twomey, P. L., Campbell, M. J., & Esserman, L. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1646-4 · Cited by 53
Melancon, M. P., Lü, W., Huang, Q., Thapa, P., Zhou, D., Ng, C. S., & Li, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.001 · Cited by 53
Tumour-associated macrophages in breast cancer and their prognostic correlations
Volodko, N., Reiner, A., Rudas, M., & Jakesz, R. (1998) · The Breast · doi:10.1016/s0960-9776(98)90065-0 · Cited by 53
Breast Cancer Management: Opportunities and Barriers to an Individualized Approach
Perez, E. A. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s1-20 · Cited by 52
Ch’ng, E. S., Sharif, S. E. T., & Jaafar, H. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1362-4 · Cited by 40
Cellular neurothekeoma with histiocytic differentiation
Misago, N., Satoh, T., & NARISAWA, Y. (2004) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2004.00223.x · Cited by 36
MR imaging of tumor-associated macrophages
Daldrup-Link, H. E., & Coussens, L. M. (2012) · OncoImmunology · doi:10.4161/onci.19456 · Cited by 34
Nariţa, D., Șeclăman, E. P., Ursoniu, S., Ilina, R. Ş., Cireap, N., & Anghel, A.-V. (2011) · PubMed · Cited by 31
Vicioso, L., Gonzalez, F. J., Alvarez, M., Ribelles, N., Molina, M., Márquez, A., Pérez, L. M. G., Matilla, A., & Alba, E. (2005) · American Journal of Clinical Pathology · doi:10.1309/0864af2u3lgpcf3j · Cited by 31
Longitudinal study of tumor‐associated macrophages during tumor expansion using MRI
Shih, Y. I., Hsu, Y., Duong, T. Q., Lin, S., Chow, K.-P. N., & Chang, C. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1698 · Cited by 30
Mukhtar, R. A., Moore, A. P., Tandon, V. J., Nseyo, O., Twomey, P. L., Adisa, C., Eleweke, N., Au, A., Baehner, F. L., Moore, D. H., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2415-2 · Cited by 30
Fernández‐Navarro, P., Pita, G., Santamariña, C., Moreno, M. P., Vidal, C., Miranda-García, J., Ascunce, N., Casanova, F., Collado-García, F., Herráez, B., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.08.026 · Cited by 26
Characterisation of macrophages infiltrating human mammary carcinomas
Steele, R. J., Brown, M., & Eremin, O. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.20 · Cited by 25
Valković, T., Dobrila, F., Melato, M., Sasso, F., Rizzardi, C., & Jonjić, N. (2002) · Cited by 24
Ruiz-Narváez, E., Rosenberg, L. A., Yao, S., Rotimi, C. N., Cupples, L. A., Bandera, E. V., Ambrosone, C. B., Adams-Campbell, L. L., & Palmer, J. R. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs334 · Cited by 23
Clinicopathologic analysis of macrophage infiltrates in breast carcinoma
Visscher, D. W., Tabaczka, P. M., Long, D., & Crissman, J. D. (1995) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80658-8 · Cited by 18
Niméus, E., Malmström, J. A., Johnsson, A., Marko‐Varga, G., & Fernö, M. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.09.019 · Cited by 16
Groisman, G. M., Amar, M., & Schäfer, I. (2002) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200209000-00003 · Cited by 16
Study, S. (.-B. S. B. C., Purrington, K. S., HEreditary Breast and Ovarian Cancer Group Netherlands (HEBON), CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella (CONSIT Team), kConFab, Wang, X., Fredericksen, Z., Pankratz, V. S., Greene, M. H., Andrulis, I. L., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2255-6 · Cited by 4
Research works printed but not linked: 1
- Laoui, 2011, Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions, Int. J. Dev. Biol., 55, 861, 10.1387/ijdb.113371dl · DOI
Cited by
Sorted by citations
Tumor-associated macrophages: from basic research to clinical application
Yang, L., & Zhang, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0430-2 · Cited by 847
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Li, X., Shao, C., Shi, Y., & Han, W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0578-4 · Cited by 389
Macrophages: Their Emerging Roles in Bone
Sinder, B. P., Pettit, A. R., & McCauley, L. K. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2735 · Cited by 309
Wang, Y., Lei, Y., Ding, J. P., & Chen, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010095 · Cited by 301
Iron as a central player and promising target in cancer progression
Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268
“Of note, the appearance of tumor-supporting, iron-donating immune cells, in particular macrophages, is associated with tumor size and aggressiveness as well as poor patient prognosis [56,57].”
Background
Metadata
- Authors
- Tang, X.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Tang, Xiaoqiang
- ORCID
- Tang, Xiaoqiang
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 332
- Issue
- 1
- Pages
- 3-10
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2077731584
- Cited by
- 276
- References
- 92
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 24 · 2023: 20 · 2022: 21 · 2021: 20 · 2020: 30 · 2019: 24 · 2018: 21 · 2017: 26 · 2016: 16 · 2015: 24 · 2014: 27 · 2013: 9
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tsinghua University
- West China Hospital, Sichuan University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor-associated macrophages, breast cancer, tumor microenvironment, M2 macrophages, CD68, prognostic factors, diagnostic biomarkers, CD163, vascular endothelial growth factor, hypoxia-inducible factor, PCNA, ferritin light chain, CCL18, TAM infiltration
- MeSH terms
- CD68 Molecule, Animals, Biopsy, Breast Neoplasms, Female, Humans, Macrophages, Predictive Value of Tests, Prognosis, Biomarkers, Tumor, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review